STOCKHOLM, SWEDEN--(Marketwire - Aug 15, 2012) - The Swedish-American Life Science Summit (SALSS) today announced that this year's SALSS conference will focus on the increasingly global nature of the Life Sciences industry with new markets like China and India fundamentally changing the industry. Leading scientists, corporate executives and investors will come together to better understand and profit from the new realities of healthcare. Some of the people who will be attending include Dr. Tachi Yamada, Chief Medical Officer and Board Member of Takeda Pharmaceuticals, Japan's largest pharma, and former CEO of the Bill and Melinda Gates Foundation; the U.S. biotech guru Steve Burrill, CEO of Burrill and Co., and Dr. William Haseltine, renowned Harvard professor and founder of Human Genome Sciences, an early pioneer of gene-based drugs.
SALSS's Chairman and Founder, Barbro C. Ehnbom, said, "It's amazing that we are gathering together in Stockholm authorities from all over the world with such depth of knowledge to explore cutting-edge technologies and create strategic and financial alliances. This year we are especially proud to have been able to attract world-famous names from Asia, such as the Indian telemedicine guru Professor K. Ganapathy, President, Telemedicine Society India, and Zhiping Cui, Vice President of International Investments, Shanghai Fosun Pharmaceutical Group -- one of China's most successful pharmaceutical companies. They can help us better understand what happens in the Life Science industry in general, and the new opportunities that exist particularly in emerging countries in Asia."
Other top international names attending the conference include Dr. Alan Moses, Global Chief Medical Officer at Novo Nordisk, a world leader in diabetes; Dr. David Blumenthal, Harvard Professor and former U.S. National Coordinator for Health under President Obama; and Paul Sekhri, Partner at one of the largest private equity firms, TPG, to name a few.
Swedish speakers at the event include the Swedish Minister for Trade, Dr. Ewa Björling, Michael Treschow, Chairman of Unilever and former Chairman of Ericsson, Dr. Laurent Leksell, Executive Director and Founder of Elekta, Dr. Charlotte Brogren, Director General, VINNOVA and Chairman, Industrifonden, Karin Johansson, State Secretary of Social Affairs as well as Mathias Uhlén, Professor, Royal Institute of Technology, among others.
Contact Information:
For more information, contact:
Sana Alajmovic
Project Manager
SALSS 2012
Email: sana@swedishamericanlifescience.com
Mobile: 076 006 57 58
Or
Leslie Wolf-Creutzfeldt
Managing Director
Grayling
leslie.wolf-creutzfeldt@grayling.com
646-284-9472
For more information, visit www.salss.com